Survodutide (6mg)

This research vial contains Survodutide, a novel dual GLP-1 and glucagon receptor agonist peptide studied for its effects on metabolic regulation, energy expenditure, and weight management pathways. Researchers have examined Survodutide in preclinical studies for its influence on appetite control, glucose metabolism, and lipid oxidation, making it a valuable compound for advanced metabolic and endocrinological research.

Blend Composition (Per Vial):
Survodutide – 6mg

Key Characteristics:

• Survodutide: Dual GLP-1/glucagon receptor agonist studied for metabolic modulation

• Investigated for effects on appetite regulation, energy expenditure, and glucose homeostasis

• Studied for its potential to enhance lipid metabolism and thermogenic activity

• Sterile vial format designed for stability, precision, and reproducible research handling

• Stable peptide formulation optimized for metabolic and peptide-based research applications

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.